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Vaccinia virus encodes at least eight proteins that incorporate label from tritiated palmitic acid when it is added to infected cell
cultures. Three of these palmitylproteins are encoded by the A33R, B5R, and F13L open reading frames and migrate by gel
electrophoresis with relative molecular masses of 23–28, 42, and 37 kDa, respectively. In this report we provide evidence that the
A22R and A36R open reading frames also encode palmitylproteins with apparent molecular masses of 22 and 50–55 kDa,
respectively. Furthermore, the hemagglutinin protein (A56R) from the Copenhagen strain is shown to be palmitylated while the
hemagglutinin protein from the WR and IHD-J strains is not. A 94-kDa VV palmitylprotein appears to be a multimeric complex
composed of the B5R protein and possibly others. All vaccinia-encoded palmitylproteins are present in the membranous fraction
of cells and are specific for the trans-Golgi network membrane-enveloped forms of the virus, suggesting that these proteins play
a role in the envelopment and egress of virions or the infectivity of released virus. © 2000 Academic Press
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Vaccinia virus (VV) is a member of the Poxviridae, a
family of large, complex DNA viruses that replicate in the
cytoplasm of infected cells (Moss, 1990). With the erad-
ication of smallpox, a closely related poxvirus, the focus
on VV biology momentarily faded, but it has been “redis-
covered” as a versatile tool for molecular biologists. This
has spurred recent efforts to characterize the virus. The
191-kb genome has been completely sequenced and
appears to encode nearly 200 gene products (Goebel et
al., 1990). Many are involved in nucleic acid metabolism
and immune modulation or serve some other nonstruc-
tural function, and about 100 are structural proteins that
are packaged with the virion.
The life cycle of vaccinia virus is well characterized
(Moss, 1990). Upon entry into cells the virus expresses a
distinct subset of early genes, leading to uncoating and
release of its genome. Genome replication commences
followed by intermediate gene expression. The interme-
diate gene products primarily serve as transcription fac-
tors for the late genes. Following late gene expression,
virion assembly occurs in concentrated cytoplasmic foci
of viral DNA, proteins, and lipids, termed viroplasm. The
formation of the first virion membrane is controversial in
that it is not entirely clear whether it is derived from the
intermediate compartment of the host (Sodeik et al.,
1993) or produced by virus-specific membrane formation
machinery (Hollinshead et al., 1999). Nevertheless, mem-
1 To whom correspondence and reprint requests should be ad-
ressed at Oregon State University, Department of Microbiology, Nashg
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193brane crescents encircle viroplasm containing a single
copy of the genome and proteinacious components of
the core. As the core condenses to the biconcave shape
typical of poxviruses, the first infectious virions, termed
intracellular mature virus (IMV), are produced. Depend-
ing on the strain of virus or cell system used, a fraction
of IMV, ranging from 25 to 40%, is targeted to the trans-
Golgi network (TGN) where, by budding through the
compartment, two additional membranes are acquired,
forming intracellular enveloped virus (IEV) (Payne, 1979).
IEV may exit the cell by two mechanisms. The first is a
passive release that is not well characterized. The sec-
ond mechanism involves the formation of “actin rockets,”
which propel the virus through and out of the cell, some-
times directly into neighboring uninfected cells (Cud-
more et al., 1995). Outside the cell, virions may remain
ttached (or reattach) to the plasma membrane or be
eleased into the extracellular environment. Virions at-
ached to the cell are referred to as cell-associated
nveloped virus (CEV); those free-floating in the extracel-
ular environment are referred to as extracellular envel-
ped virus (EEV).
VV serves as an ideal model system for the study of
rotein processing for several reasons. VV proteins (or
xogenous proteins expressed either transiently from
ransfected plasmids or from recombinant VV) are sub-
ect to modifications typical of mammalian systems, to
nclude sulfation (Payne, 1992), phosphorylation, ADP-
ibosylation, glycosylation, and as highlighted here, acy-
ation (VanSlyke and Hruby, 1990). Its genes are ex-
ressed in the cytoplasm without mRNA processing,
llowing prediction of gene products directly from the
enomic sequence. We have previously observed that
any VV proteins are acylated, providing numerous sub-
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194 GROSENBACH, HANSEN, AND HRUBYjects for study (Child and Hruby, 1992; Franke et al., 1989;
Ravanello and Hruby, 1994a). Acylation of VV polypep-
tides has been demonstrated to play a major role in the
assembly of virions.
At least four VV proteins are myristylated on glycine of
the amino-terminal motif, composed of the initiator methio-
nine, followed by a glycine residue, a three-amino-acid
spacer with no specific residue requirement, and then a
serine, threonine, alanine, cysteine, or asparagine in the
last position (MGXXXS/T/A/C/N) (Martin et al., 1997). The
ost studied of these is the 25-kDa protein product of the
1R open reading frame.
It has also been previously demonstrated that there
re at least six VV-induced palmitylproteins present in
nfected cells (Child and Hruby, 1992). They are all local-
zed to the membrane fraction of cells and, when virion
ssociated, are present in the outer membrane fraction
f CEV and EEV. Three VV palmitylproteins are encoded
y open reading frames A33R (Roper et al., 1996), B5R
Isaacs et al., 1992), and F13L (Hirt et al., 1986), while
nknown open reading frames encode the remaining VV
almitylproteins.
Palmitylation of proteins involves the transfer of palmi-
ate, a 16-carbon saturated fatty acid, from palmityl-co-
nzyme A to cysteines, serines, or threonines through
hioester or ester linkage (Magee and Schlesinger, 1982;
chlesinger et al., 1980; Schmidt, 1983). The modification
is made posttranslationally and in most cases by an
unidentified enzyme or enzymes referred to as palmityl-
protein acyltransferase (Berthiaume and Resh, 1995;
Schmidt and Burns, 1991). Some reports suggest that, at
least for a small number of proteins, a nonenzymatic or
autocatalytic mechanism is sufficient to mediate acyl-
transfer (Berger and Schmidt, 1984; Bharadwaj and Biz-
zozero, 1995; Bizzozero and Lees, 1986). The modifica-
tion is reversible in vivo and often modulates function or
subcellular localization of proteins.
Although many cellular and viral palmitylproteins have
been characterized with regard to site(s) of modification,
a definitive structural motif specifying palmitylation of
proteins has not been identified. Palmitylproteins have
been separated into four separate classes based on
membrane topology, prior modification by myristate or
isoprenyl moieties, and relative to the termini, which
region of the protein is modified (Resh, 1996). We have
previously reported that the palmitate acceptor resi-
due(s) of proteins may be predicted by the consensus
motif, Hydro*1–12AACA (Grosenbach et al., 1997; Hansen
et al., 1999). The hydrophobic element (Hydro*) may be a
transmembrane domain, a hydrophobic sequence of
amino acids, or a glycine residue that has been cotrans-
lationally myristylated. It is followed by a 1 to 12-amino-
acid spacer that precedes aliphatic residues (A) sur-
rounding the palmitylated cysteine (C). This motif is
based on work in our laboratory as well as on the work
of others (Bizzozero et al., 1994; Ivanova and Schlesinger,1993; Ponimaskin and Schmidt, 1995; Schmidt, 1989;
Schmidt et al., 1995; Veit et al., 1996).
Here we report the identification of previously un-
known palmitylproteins encoded by the A22R, A36R, and
A56R (Copenhagen strain) open reading frames of VV.
We also tested our ability to predict the palmitylated
residue by site-directed mutagenesis and analysis of
palmitate incorporation by the mutated proteins.
RESULTS
Analysis of VV acylproteins
VV proteins are expressed in three distinct temporal
classes: early, intermediate, and late. In an effort to limit the
number of proteins to target for our study we performed a
time-course labeling experiment with [9,10-3H(N)]myristic
acid ([3H]MA) and [9,10-3H(N)]palmitic acid ([3H]PA) to de-
termine their temporal class. BSC40 cells were synchro-
nously coinfected with the Copenhagen (COP) and Western
Reserve (WR) strains of VV at a combined multiplicity of
infection (m.o.i.) of 10. During this study, we observed strain-
specific acylproteins (both myristyl- and palmitylproteins)
(see Fig. 2). Coinfection with COP and WR allowed the
analysis of all VV-encoded acylproteins within a single set
of experiments. The infected cells were labeled by addition
of [3H]PA or [3H]MA from 0- to 1-, 1- to 2-, 2- to 4-, 4- to 8-,
nd 8- to 24 h postinfection (hpi). The infected cells were
arvested at the end of each labeling period. The total cell
xtracts were resolved by SDS–PAGE, followed by fluorog-
aphy, and then exposed to film. With the exception of a
4-kDa protein that incorporated label from both myristic
nd palmitic acid in the 1- to 2-hpi labeling period, all other
cylproteins encoded by VV appear to be “late” proteins
Fig. 1). The 14-kDa acylprotein continued to incorporate
abel from 2- to 8-hpi but was nearly absent in the 8- to
4-hpi labeling period. All other VV acylproteins incorpo-
ated label in the 2- to 4-, 4- to 8-, and 8- to 24-hpi labeling
eriods. To distinguish between authentic myristylproteins
nd those that were labeled via interconversion to palmitic
r other long-chain fatty acids, identical gels were treated
ith neutral hydroxylamine prior to fluorography (Figs. 1B
nd 1D). Vaccinia encodes palmitylproteins with apparent
olecular masses of 14-, 17-, 23–28- (a single glycoprotein
ith a common peptide backbone migrating as three dis-
inct species), 37-, 42-, 50–55-, and 94 kDa (Fig. 1A).
Additionally, the COP strain produced an 86-kDa protein
hat was not detectable in the WR- or International Health
epartment strain J (IHD-J)-infected cell extracts (Fig. 2A).
he 23-, 28-, 37-, and 42-kDa proteins have previously been
eported to be encoded by the A33R (Roper et al., 1996),
13L (Hirt et al., 1986), and B5R (Isaacs et al., 1992) open
reading frames, respectively. The identities of the 14-, 17-,
50- to 55-, 86-, and 94-kDa palmitylproteins are unknown
and represent the topic of this report.The myristylproteins migrated with apparent molecular
masses of 14-, 17-, 25-, 36-, 39-, and 92 kDa (Fig. 1C). The
y acids
mine tr
195VV PALMITYLPROTEINS92-kDa myristylprotein was not produced by the COP strain
(Fig. 2A) and most likely is the ATI protein encoded by the
A25L open reading frame of WR and IHD-J as previously
reported (Funahashi et al., 1988; Meyer and Rziha, 1993).
The 25-kDa myristylprotein is encoded by the L1R open
reading frame and has been the subject of numerous stud-
ies (Franke et al., 1990; Ravanello and Hruby, 1994a,b;
Wolffe et al., 1995). We have recently reported that the 17-,
36-, and 39-kDa proteins are encoded by the E7R, A16L,
and G9R open reading frames, respectively (Martin et al.,
1997). In a single report, the 14-kDa myristylprotein was
identified as the product of the A14L open reading frame
(Rodriguez et al., 1997), a finding that is not supported by
our work (see below).
Subcellular fractionation and virion association of VV
acylproteins
FIG. 1. SDS–PAGE analysis of time-course-labeled VV acylproteins. BS
of 10. Cells were labeled with [3H]PA (A and B) or [3H]MA (C and D) for
were treated with neutral hydroxylamine to cleave thioester-bonded fatt
to film exposure. Note the 14-kDa acylprotein recalcitrant to hydroxylaThe L1R myristylprotein is known to be a component
of both IMV and EEV (Ravanello et al., 1993; Ravanelloand Hruby, 1994b). The A33R (Roper et al., 1996), B5R
(Isaacs et al., 1992; Wolffe et al., 1993), and F13L
(Blasco and Moss, 1991) palmitylproteins are known to
be specific for TGN membrane-enveloped virions (IEV,
CEV, and EEV) and are found in TGN membranes prior
to envelopment (Schmelz et al., 1994). To determine
the intracellular locations of the other acylproteins, we
fractionated infected, labeled cells by differential cen-
trifugation to yield a nuclear fraction, a particulate
cytosolic fraction (containing whole virions and cyto-
solic membranous components), and a soluble cyto-
plasmic fraction. We also purified IMV and EEV from
labeled cells. The L1R myristylprotein was present in
the nuclear fraction and the membrane fraction, which
also contains whole virions (Fig. 3B). It was also
present on IMV and EEV. All other myristylproteins
were found in the soluble fraction of cells, although a
lls were coinfected with WR and COP strains of VV at a combined m.o.i.
riods as indicated above the gel lanes (h postinfection). Identical gels
(B and D). All gels were fluorographed by impregnation with PPO prior
eatment in B and D.C40 ce
time pesmall amount of the G9R protein is also present in IMV.
All VV palmitylproteins found in total cell extracts were
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196 GROSENBACH, HANSEN, AND HRUBYpresent in the nuclear fraction and the membrane
fraction, and were specific for EEV (Fig. 3A). Two
additional palmitylproteins with apparent molecular
masses of 20- and 22 kDa that were not obvious in the
total cell extracts were present on EEV as well. No VV
palmitylproteins were found to be soluble or on IMV.
Identification of candidate palmitylproteins
To identify candidate palmitylproteins, we consid-
ered that VV palmitylproteins are of the late temporal
FIG. 2. Comparison of acylproteins encoded by COP, IHD-J, and WR
Cells were labeled by addition of [3H]PA or [3H]MA. Total cellular extrac
of PPO-impregnated gels to film (A). An identical gel was treated with
absence of a 92-kDa myristylprotein ([3H]MA) from COP extracts. Also n
from IHD-J and WR extracts.class; are specific for IEV, CEV, or EEV; and most likely
contain hydrophobic sequences mediating membrane
i
A
ytosolic fraction (S20). IMV was purified from infected cells. Subcellular fracti
luorographed to detect [3H]PA- or [3H]MA-labeled proteins.association. We then scanned the sequence of the
COP strain (which is entirely sequenced) (Goebel et
l., 1990) for open reading frames preceded by late
romoters and encoding proteins whose predicted
ass corresponded to SDS–PAGE observed mobility
f VV palmitylproteins. These sequences were then
nalyzed for hydrophobic regions and for cysteines
hat were within the consensus, Hydro*1–12AACA. By
hese criteria the following open reading frames were
of VV. BSC40 cells were infected with COP, IHD-J, or WR strains of VV.
e resolved by SDS–PAGE and acylproteins were detected by exposure
al hydroxylamine to cleave thioester-bonded fatty acids (B). Note the
presence of an 86-kDa palmitylprotein in COP extracts that is absentdentified as potentially encoding palmitylproteins:
14L, A22R, A33R, A34R, A36R, A56R, B5R, and F13LFIG. 3. Differential centrifugal subcellular fractionation of VV acylproteins. BSC40 cells were coinfected with COP and WR strains of VV. These
infected cells were labeled with [3H]PA (A) or [3H]MA (B). EEV was purified from the culture medium. A portion of the total cell extracts (TCE) was
ractionated to yield a nuclear fraction (NP); a particulate cytosolic fraction (P20), containing intracellular membranes and whole virions; and a solublestrains
ts wer
neutrons and equal titers of IMV and EEV were resolved by SDS–PAGE and
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197VV PALMITYLPROTEINS(Fig. 4). It has been previously reported that the prod-
ucts of the A33R (Roper et al., 1996), B5R (Isaacs et al.,
1992), and F13L (Hiller and Weber, 1985; Hirt et al.,
1986) open reading frames are palmitylproteins, which
led us to conclude that our criteria were sufficient.
Additionally, the products of the A33R (Roper et al.,
1996), A34R (Duncan and Smith, 1992), A36R (Parkin-
son and Smith, 1994), A56R (Payne and Norrby, 1976),
B5R (Engelstad et al., 1992; Isaacs et al., 1992), and
F13L (Hiller and Weber, 1985; Hirt et al., 1986) open
reading frames are specific for IEV, CEV, or EEV, fur-
ther supporting these as candidate palmitylproteins.
Transient expression and palmitylation of candidate
palmitylproteins
The open reading frames for each candidate palmitylpro-
tein were PCR amplified from VV genomic DNA and cloned
into a modified pTM1 vector, pTM1:6xHis. This vector con-
tains sequences that, following expression, result in the
addition of a carboxyl-terminal 6-histidine tag on each of the
candidate palmitylproteins. The T7 promoter and encepha-
lomyocarditis virus 59 untranslated region (EMC leader) are
left intact as well. Following infection of cells with vTF7–3 (a
T7 polymerase expressing recombinant vaccinia virus), the
T7 promoter is recognized by the virus-produced T7 poly-
merase, mediating high-level transcription. The EMC leader
present on the transcript serves as an internal ribosomal
entry site mediating cap-independent translation. For these
experiments, BSC40 cells were infected with vTF7–3, fol-
lowed by transfection of each of the plasmid DNAs in
3
FIG. 4. Identification of candidate VV palmitylproteins. VV proteins (pr
Only proteins whose promoters contain the consensus “late” transcripti
for further evaluation. Late promoter elements are underlined. Num
nucleotides shown. The A56R gene does not contain a consensus “l
sequences of VV late proteins were inspected for homology to the p
(underlined) with cysteine residues in an aliphatic environment (C*) were
to the SDS–PAGE observed mobility (numbers in parentheses under “Sseparate 35-mm wells. At 4 hpi [ H]PA was added to the
culture medium. Infected cells were harvested at 24 hpi and
A
pthen two equal portions of the total cell extract were re-
solved by SDS–PAGE on two different gels. The first gel was
electroblotted to nitrocellulose and probed with Ni1-acti-
ated horseradish peroxidase, which binds to the 6-histi-
ine tag on the transiently expressed proteins. The blot was
eveloped using chemiluminescent reagents and exposed
o film. The other gel was impregnated with diphenylox-
zole:dimethyl sulfoxide (PPO:DMSO), dried, and exposed
o film for detection of all [3H]PA-labeled proteins. The
remaining portions of the total cell extracts were immuno-
precipitated. The immunoprecipitated proteins were re-
solved by SDS–PAGE and analyzed as described earlier.
The affinity blot (referring to the Ni1-activated horse-
adish peroxidase-probed blot) demonstrated that all of
he proteins were efficiently expressed by the vTF7–3/
TM1:6xHis system (Fig. 5A). We observed that A14L
ncodes a protein of 14 kDa with minor species migrat-
ng at approximately 16- and 23 kDa; A22R encodes a
2-kDa protein; A33R encodes three proteins migrating
t 23-, 25-, and 28 kDa; A34R encodes two proteins
igrating at 22- and 24 kDa; A36R encodes a protein
oorly resolving between 50- and 55 kDa; A56R encodes
ossibly three proteins resolving between 72- and 86
Da; B5R encodes a 42-kDa protein and is present in a
igher-molecular-weight complex of approximately 94
Da; and F13L encodes a 37-kDa protein. The multiple
anding seen by SDS–PAGE for A33R, A34R, A36R, and
56R is most likely the result of a complex glycosylation
attern for these proteins. The fluorograph of the same
ell extracts, labeled with [3H]PA, demonstrates that the
from gene sequences) were evaluated as candidates for palmitylation.
t sequence upstream of the start codon ATG (in bold) were considered
parentheses indicate the number of nucleotides that separate the
moter but is included for additional reasons (see text). The peptide
ation motif Hydro*1–12AACA. Proteins containing hydrophobic regions
dered for further analysis. The predicted size of the protein is comparededicted
on star
bers in
ate” pro
almityl14L, A34R, and A56R (WR strain) proteins did not incor-
orate the label above background levels, suggesting
and w
ated a
198 GROSENBACH, HANSEN, AND HRUBYthat they are not palmitylproteins (Figs. 5B and 5C).
Proteins expressed from A22R, A33R, A36R, A56R (COP
strain), B5R, and F13L incorporated the label above back-
ground levels, suggesting that these open reading
frames do encode palmitylproteins. Although sequence
analysis of the cloned genes demonstrated that the his-
tidine tag was intact on all the plasmid constructs, we
were unable to immunoprecipitate A22R and B5R using
anti-6-histidine monoclonal antibodies (Fig. 5C). This
FIG. 5. Transient expression and [3H]PA labeling of VV candidate pal
cells using the vTF7–3/pTM1:6xHis system. Proteins were labeled by a
identical gels (A and B). One gel (A) was blotted to nitrocellulose and p
proteins. The blot was developed using chemiluminescent reagents
palmitylproteins in the cellular extracts. Histidine-tagged proteins were
monoclonal antibody. Immunoprecipitates were resolved by SDS–PAGE
(C). Gel lane assignments are identical for all three gels and are indicmay be the result of protein conformations that deny the
antibody access to the histidine tag during the immuno-precipitation reaction. It has been previously demon-
strated that the A33R, B5R, and F13L genes encode
palmitylproteins, although the modification status of
A22R, A36R, and A56R (COP strain) has not been re-
ported previously.
Identification of palmitate-modified residues of VV
palmitylproteins
teins. Candidate palmitylproteins were transiently expressed in BSC40
of [3H]PA to infected cells. Total cellular extracts were resolved on two
with Ni1-activated horseradish peroxidase that binds histidine-tagged
xposed to film. The other gel (B) was fluorographed to detect all
oprecipitated from the same cellular extracts using an anti-6-histidine
ere also fluorographed to detect immunoprecipitated palmitylproteins
bove gel “A”.mitylpro
ddition
robed
and e
immunTo narrow the number of residues that might be subject
to palmitylation, each of the VV palmitylprotein sequences
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199VV PALMITYLPROTEINSwas examined for cysteine residues that fell within the
context of the palmitylation motif, Hydro*1–12AACA. We also
onsidered that those regions of proteins exposed to the
umenal compartment of intracellular organelles or the ex-
racellular environment were unlikely to be palmitylated. By
hese analyses it was predicted that the following residues
denoted by the single-letter amino acid code and residue
umber starting from the initiating methionine) were palmi-
ylated: C99 of A22R, C36 of A33R, C19 or C25 of A36R,
296 or C301 of A56R, C301 or C303 of B5R, and C185
nd/or C186 of F13L. The codons for these residues were
utated, by oligonucleotide (oligo)-directed mutagenesis,
o encode serine instead of cysteine. In the case of F13L,
oth cysteine 185 and 186 were mutated to serine, since it
as been previously demonstrated to be palmitylated on
oth residues (Grosenbach et al., 1997). Also, since we
ave observed that the COP-encoded A56R is palmitylated
ut is not palmitylated as expressed from the WR or IHD-J
trains (data not shown for IHD-J), their amino acid se-
uences were analyzed for differences occurring in the
egion predicted to be palmitylated. The only difference
oted was that a tyrosine residue in both WR and IHD-J
eplaced C301 from COP A56R. Tyrosine is not known to be
n efficient substrate for palmitylation, suggesting that C301
as the palmitate acceptor residue in that protein.
Each of the mutated proteins was transiently ex-
ressed and analyzed by SDS–PAGE as described ear-
ier (Fig. 5). The C99 mutant of A22R still incorporated
abel as efficiently as the wild-type protein, perhaps even
ore efficiently. It was found that the C36 mutant of A33R
lso incorporated label but at a slightly lower level than
he wild-type protein. This may be because of differences
n expression levels, though, and as such C36 may not
e the palmitate-acceptor residue. The C19 mutant of
36R incorporated label as efficiently as the wild-type
rotein, whereas the C25 mutant of A36R incorporated
ery little, suggesting that C25 is the primary palmitate-
cceptor residue for A36R. The C301 mutant of B5R
ncorporated very little label, suggesting it is the primary
almitate-acceptor residue. The C303 mutant of B5R
ncorporated less than the wild-type protein but more
han the C301 mutant, suggesting possibly a secondary
odification site. In previous reports we have demon-
trated that F13L is palmitylated on C185 and C186. This
s supported by the data presented here. The C185/186
utant of F13L did not incorporate label at detectable
evels above background.
yristic acid labeling of the A14L protein
It has been previously reported that the A14L protein is
yristylated (Rodriguez et al., 1997). We attempted to
onfirm this by transient expression of the A14L protein
sing the vTF7–3/pTM1:6xHis system. Although the pro-ein was efficiently expressed (Fig. 6A), it did not incor-
orate the label (Fig. 6B). We noticed, though, that over-
p
[xpression of the A14L protein inhibited the production
f other late VV myristylproteins, whereas the intermedi-
te 14-kDa myristylprotein was still expressed at a low
evel (Fig. 6B).
DISCUSSION
In identifying candidates for this study, a number of
riteria were utilized. First, we considered the work of
thers to identify both viral and cellular palmitylproteins
nd their sites of modification (Bizzozero et al., 1994;
ietzen et al., 1995; Ivanova and Schlesinger, 1993; Koegl
t al., 1994; Magee and Courtneidge, 1985; Ponimaskin
nd Schmidt, 1995; Schmidt et al., 1995; Veit et al., 1996).
n doing so, we observed a loosely conserved motif
ydro*1–12AACA (described earlier) (Grosenbach et al.,
1997; Hansen et al., 1999).
This motif by itself did not allow the identification of VV
palmitylproteins. Therefore, as a second means of iden-
tifying VV palmitylproteins, we undertook a biochemical
characterization of palmitylated proteins expressed in
VV-infected cells. Table 1 summarizes the results de-
scribed here and elsewhere. We first made an effort to
distinguish between VV myristylproteins and VV palmi-
tylproteins, many of which comigrate when resolved by
SDS–PAGE. One of our first discoveries was that the ATI
protein, which we previously thought to be modified by
both myristate and palmitate (Martin, 1997), is in fact only
myristylated. This was determined by the analysis of
[3H]MA- or [3H]PA-labeled extracts from cells infected
ith the COP, IHD-J, or WR strains of vaccinia. We ob-
erved that an 86-kDa palmitylprotein that was absent
rom the extracts from IHD-J or WR-infected cells was
xpressed by COP (Fig. 2). A 94-kDa palmitylprotein was
FIG. 6. [3H]MA labeling of the VV A14L protein. BSC40 cells were
infected with vTF7–3 and transfected with pTM1:A14L-6xHis. Cells
were labeled by addition of [3H]MA. Total cellular extracts were re-
solved by SDS–PAGE on two identical gels. One gel was blotted to
nitrocellulose and probed with Ni1-activated horseradish peroxidase
A). The other gel was developed using chemiluminescent reagents
nd exposed to film. The other gel was fluorographed to detect [3H]MA-
labeled proteins (B).resent in the extracts from all three viruses. In the
3H]MA-labeled extracts we observed a 92-kDa myristyl-
m
w
s
been id
200 GROSENBACH, HANSEN, AND HRUBYprotein encoded by IHD-J and WR but not COP. It is
known that the COP strain contains a mutation in the
A25L gene, encoding the ATI protein, which results in the
premature termination of translation, giving rise to a
truncated peptide (Goebel et al., 1990; Patel et al., 1986).
Considering, though, that COP encodes palmitylproteins
of 86- and 94 kDa it is likely that because of the similar
migration rates in SDS–PAGE gels that the 94-kDa palmi-
tylprotein (also expressed by WR and IHD-J) and the
92-kDa myristylprotein were considered to be one and
the same. This finding further supports our conclusion
that the ATI protein is not palmitylated and that, with the
exception of L1R, all VV myristylproteins are soluble in
the cytoplasm of infected cells, whereas all VV palmityl-
proteins are found in the particulate fraction of infected
cells. A remote possibility exists that the ATI protein is
palmitylated and, once it is, becomes a component of the
particulate fraction of cells. This does not seem likely,
though, because a 92-kDa palmitylprotein, present in
extracts from WR and IHD-J but not COP, has not been
observed.
Also, in comparing the acylproteins expressed by the
COP, IHD-J, and WR strains of VV, we noted that COP
encoded an 86-kDa palmitylprotein whose migration pat-
tern in SDS–PAGE gels suggested that it was a glyco-
protein. We also observed what appeared to be the same
protein present on EEV. It is known that the VV hemag-
glutinin protein (encoded by gene A56R) exhibits similar
characteristics, so we considered it a candidate for
T
Summary o
Protein/gene Modification
ATI/A25L Myristate
Unnamed/A16L* Myristate
Unnamed/G9R* Myristate
M25/L1R* Myristate
Unnamed/E7R* Myristate
M14/unknown Myristate
Hemagglutinin/A56R Palmitate
Unnamed/A36R Palmitate
gp42/B5R* Palmitate
P37/F13L* Palmitate
Unnamed/A33R* Palmitate
Unnamed/A22R Palmitate
P17/unknown Palmitate
Unnamed/A14L Nonacylated
Unnamed/A34R Nonacylated
a Labeling experiments with [3H]MA or [3H]PA have shown that VV e
yristyl- and palmitylproteins. Modification with myristate can occur at
ithin the consensus sequence MG*XXX(S,T,A,C,N). VV palmitylation
equence Hydro*1–12AACA. The ORF that encodes the 14-kDa myristylp
been discovered. The ORFs encoding for the palmitylproteins have all
and localization of each protein are listed in the table.palmitylation. Analysis of the protein expressed by the
COP A56R gene suggested that either C296 or C301would be possible palmitate-acceptor residues. C296,
although surrounded by aliphatic residues, is within the
predicted transmembrane region. C301 is at the mem-
brane/cytosolic boundary but is followed by the amide of
aspartic acid, asparagine. We sequenced the IHD-J A56R
gene and compared it to the WR and COP sequences.
The amino acid sequences from the transmembrane
domain through the cytoplasmic tails for all three pro-
teins were identical to position 301, which was the ex-
ception. Although COP had a cysteine at position 301,
both IHD-J and WR had a tyrosine residue. Considering
that we have observed the COP hemagglutinin to be
palmitylated, while the IHD-J and WR hemagglutinin are
not, we must conclude that C301 is the palmitate-accep-
tor residue. Payne (1992) first demonstrated that the
IHD-J hemagglutinin was not palmitylated but did not
analyze the WR- or COP-encoded hemagglutinin.
As part of our biochemical characterization of VV acyl-
proteins, we performed a time-course labeling experi-
ment to determine the temporal class to which the VV
acylproteins belong. All VV myristyl- and palmitylproteins
are primarily expressed at late times, suggesting a role
in assembly. The one exception is the 14-kDa acylprotein
that incorporated both myristic and palmitic acid label.
Identical expression characteristics and size suggest
that they are the same protein. Both the myristic- and
palmitic acid-labeled 14-kDa acylproteins commenced
expression in the 1- to 2-hpi labeling period, continued
expression through the 2- to 8-hpi labeling period, and
ylproteinsa
Site of modification Localization
Unknown (Internal) Cytosol, IMV
MG*XXX(S,T,A,C,N) Cytosol
MG*XXX(S,T,A,C,N) Cytosol, IMV
MG*XXX(S,T,A,C,N) IMV, EEV
MG*XXX(S,T,A,C,N) Cytosol
Unknown (Internal) Unknown
Cysteine 301 EEV
Cysteine 25/? IEV
Cysteines 301/303 TGN, IEV, CEV, EEV
Cysteines 185/186 TGN, IEV, CEV, EEV
Cysteine 36 TGN, IEV, CEV, EEV
Unknown EEV
Unknown Unknown
Nonacylated IMV, EEV
Nonacylated IEV, CEV, EEV
numerous acylated proteins. Depicted in the table are the known VV
rnal site on a arginine or lysine, or at the amino terminus on a glycine
mostly on cysteine residues within a loosely conserved consensus
(M14) has yet to be identified; therefore, the modification site has not
entified except for the 17-kDa species (P17). Known modification sitesABLE 1
f VV Ac
ncodes
an inte
occurs
roteinwere not detectable in the 8- to 24-hpi labeling period.
The possibility that both the myristylated and palmity-
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201VV PALMITYLPROTEINSlated proteins are the same is supported by the fact that
a fraction of the label, whether added as myristic or palmitic
acid, incorporated by the 14-kDa protein was recalcitrant to
treatment by neutral hydroxylamine (Figs. 1B and 1D),
which is known to cleave thioester-linked moieties such as
palmitate (Schlesinger et al., 1980). This suggests that at
least part of the label incorporation was the result of the
formation of neutral hydroxylamine-stable amide linkage as
is typical of myristylation. Vaccinia is not predicted to en-
code a 14-kDa protein containing the amino-terminal myri-
stylation motif MGXXXS/T/A/C/N and, therefore, suggests
that this 14-kDa protein is the second example of a VV-
encoded, internally myristylated protein, the first of which is
the ATI protein. It has been previously reported that the
A14L gene encodes a 14-kDa myristylprotein (Rodriguez et
al., 1997). We attempted to confirm this and to determine
whether this same protein was palmitylated as well. Over-
expression of the A14L gene in the presence of [3H]PA or
3H]MA did not result in the incorporation of either label by
the protein, although the protein was expressed at a high
level (Figs. 5 and 6). We did note, though, that the high-level
expression of A14L inhibited other late protein production.
We not only have identified novel palmitylproteins en-
coded by the A22R, A36R, and A56R (COP strain) genes
of VV, but also have been able to accurately predict the
palmitate-acceptor residue for A36R-, A56R-, B5R-, and
F13L-encoded proteins. Although, by our analyses, VV
proteins appear to be palmitylated in a predictable man-
ner, the misidentification of the A14L and A34R proteins
as candidate palmitylproteins and the inability to predict
the modification sites on the A22R and A33R proteins
suggest shortcomings to our system for identification of
VV palmitylproteins. Perhaps additional criteria should
be considered. The A14L protein is known to be a com-
ponent of the IMV membrane and the inner membrane of
EEV. Although the primary amino acid sequence indi-
cates that it could be a substrate for palmitylation, its
presence in the IMV membrane may sequester it from
the palmitylation machinery. It is not clear to us why a
protein in the membrane of IMV would not be palmity-
lated, while a protein in the membrane of EEV would be.
Another factor that must be considered is membrane
orientation. The A36R protein is predicted to be a type Ib
membrane protein and, as such, the most likely palmi-
tate-acceptor residue would be exposed to the lumenal
environment of intracellular membrane-bound compart-
ments or to the extracellular environment if it were ex-
ported to the plasma membrane. Palmitylation most com-
monly occurs on regions of proteins exposed to the
cytoplasm. The finding that A36R is palmitylated on C25
and data generated from Ro¨ttger et al. (1999) and van Eijl
et al. (2000) conclusively demonstrate that this protein
has a type Ib membrane oreintation, with a short amino-
terminal lumenal tail and a long carboxyl-terminal cyto-
plasmic tail. Membrane orientation may explain why the
A34R protein is not palmitylated. The A34R protein is
c
wpredicted to be a type II transmembrane protein with a
long, lumenally exposed carboxyl-terminal tail. The pre-
dicted orientation appears to be correct based on the
findings of Ro¨ttger et al. (1999). Even though the primary
amino acid sequence is an exact match for what we
define as an optimal consensus for palmitylation, the
presence of the motif in the lumenal compartment may
preclude palmitylation.
In this same report by Ro¨ttger et al. (1999) the type II
membrane orientation for the A33R protein was con-
firmed. Only one cysteine residue (C36) is present in the
cytoplasmic domain of the protein. When C36 is changed
to serine by oligo-directed mutagenesis the A33R protein
still incorporated [3H]PA label, although at slightly re-
uced efficiency. Serine was chosen to replace cysteine
ecause of similar biochemical characteristics such as
ize and the polar side chain. In retrospect, this may not
ave been the best choice. Serine and threonine are also
ubstrates for palmitylation, but only rarely (Bizzozero et
l., 1994; Schmidt and Lambrecht, 1985). It may be that
eplacement of a palmitate-acceptor cysteine with a
erine in an optimal environment results in palmitylation
f the serine residue through ester linkage.
Many VV palmitylproteins are thought to interact either
hrough disulfide bonds or noncovalently (Payne, 1992;
o¨ttger et al., 1999). The exact nature of these interac-
ions or their biological significance is not known. These
ame proteins are involved in the formation of IEV, the
recursor of EEV; in the propulsion of the IEV particle
hrough and out of cells by actin polymers; or in the
nfectivity of released virions. They are all specific for the
GN-enveloped virions and, prior to virion envelopment,
re found associated with the membranes of the TGN
Schmelz et al., 1994). It is not likely a coincidence that
any of these same proteins are palmitylated. It may be
hat the palmitate moiety targets these proteins to their
espective intracellular location, i.e., the TGN. Alterna-
ively, it may be that the palmitate moiety stabilizes hy-
rophobic protein/protein interactions. We have previ-
usly reported that, at least for the F13L protein (p37), the
almitate modification is necessary for TGN association
Grosenbach and Hruby, 1998; Grosenbach et al., 1997).
mutant of p37 that is not palmitylated is soluble in the
ytoplasm of infected cells and cannot function effi-
iently with regard to envelopment of IMV. It will be of
nterest to determine the biological significance of the
almitylation of the other VV palmitylproteins.
VV continues to stand out as an excellent system for
he study of mammalian protein processing. VV proteins
or exogenous proteins expressed either transiently from
ransfected plasmids or from recombinant VV) are sub-
ect to modifications typical of mammalian systems, to
nclude sulfation, phosphorylation, ADP-ribosylation, gly-
osylation, and as highlighted here, acylation. The ease
ith which VV is genetically manipulated has facilitated
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202 GROSENBACH, HANSEN, AND HRUBYthe study of numerous VV gene products, leading to the
identification of three novel VV palmitylproteins.
MATERIALS AND METHODS
Cells and viruses
BSC40 (African green monkey kidney) and RK13 (rabbit
kidney) cell lines were cultured in Eagle’s minimal es-
sential medium supplemented with 10% (v/v) fetal bovine
serum, 2 mM L-glutamine, and 10 mg/ml gentamicin-
sulfate (MEM-10 LG/GS) at 37°C in a 5% CO2-humidified
atmosphere. Upon infection with VV, the cells were then
cultured in Eagle’s minimal essential medium supple-
mented with 2 mM L-glutamine and 10 mg/ml gentamicin-
sulfate (MEM LG/GS) at 37°C in a 5% CO2-humidified
tmosphere. The Copenhagen (COP), IHD-J, and WR
trains of VV were routinely propagated and titered in
SC40 cells as previously described (Earl et al., 1992).
The recombinant VV, vTF7–3 (Fuerst et al., 1986), was
used for transient expression of genes cloned into the
plasmid vector, pTM1:6xHis (described below). This virus
contains of copy of T7 gene 1 inserted at the thymidine
kinase locus of the VV genome and expresses T7 RNA
polymerase nearly constitutively during infection. Genes
downstream of a T7 promoter are expressed to high
levels when present in the cytoplasm of vTF7–3-infected
cells. Standard methods were used to propagate and
titer this virus as well.
Metabolic labeling of VV proteins with [3H]myristic
acid and [3H]palmitic acid
[9,10-3H(N)]Myristic acid ([3H]MA, Dupont/NEN Re-
earch Products, Boston, MA) and [9,10-3H(N)]palmitic
cid ([3H]PA, Dupont/NEN Research Products), pur-
chased as ethanolic solutions, were dried by nitrogen
overflow. The lipids were then dissolved in dimethyl
sulfoxide (DMSO) at a concentration of 10 mCi/ml.
abeling of COP, IHD-J, and WR acylproteins
BSC40 cells were grown to confluency in 35-mm wells
106 cells/well). The cells were synchronously infected
ith COP, IHD-J, or WR strains of VV at a multiplicity of
nfection (m.o.i.) of 10. At 4 h postinfection (hpi), [3H]MA
or [3H]PA was added to a final concentration of 100
mCi/ml in no more than 10 ml of DMSO. At 24 hpi the cells
ere harvested and resuspended in reducing sodium
odecyl sulfate–polyacrylamide gel electrophoresis
SDS–PAGE) sample buffer and frozen until needed.
ime-course labeling
BSC40 cells were grown to confluency in 35-mm wells.
The cells were synchronously coinfected with COP and
WR strains of VV at a m.o.i. of 10 each (final m.o.i. 5 20),o that both COP-specific and WR-specific palmitylpro-
eins could be observed in the same context. Labeledipids were added to a final concentration of 100 mCi/ml
n no more than 10 ml of DMSO. The labeling periods
included the 0- to 1-, 1- to 2-, 2- to 4-, 4- to 8-, and 8- to
24-hpi time points. Infected cells were immediately har-
vested at the end of the labeling periods and resus-
pended in reducing SDS–PAGE sample buffer and frozen
until needed.
Labeling infected cells for subcellular fractionation
and purification of IMV and EEV
BSC40 cells were grown to confluency on 150-mm
tissue-culture plates (2 3 107 cells). The cells were
oinfected with the COP and WR strains of VV at a m.o.i.
f 5 each (final m.o.i. 5 10). At 4 hpi [3H]PA was added to
a final concentration of 100 mCi/ml. At 24 hpi both the
culture medium and the infected cells were collected for
purification of IMV and EEV and for subcellular fraction-
ation of VV palmitylproteins. The culture supernatant was
clarified of cellular debris by centrifugation at 700 g for
20 min. Labeled EEV was then pelleted from the clarified
culture medium by centrifugation at 100,000 g for 30 min.
he EEV pellet was resuspended in 500 ml of phosphate-
buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 4.3 mM
Na2HPO4z7H2O, 1.4 mM KH2PO4), titered, and then frozen
until needed. The infected cells were resuspended in 6
ml of PBS, rapidly frozen, and then thawed to lyse cells.
To ensure cell lysis the cellular extracts were vortexed
vigorously while still partially frozen, using the ice crys-
tals to homogenize the cell extracts. A 1-ml aliquot of the
infected cell lysate was set aside for subcellular fraction-
ation. IMV was purified from the remaining 5-ml of cell
lysate using CsCl gradients following techniques stan-
dard for VV (Payne, 1980).
Differential centrifugal subcellular fractionation of VV-
infected cell extracts
From the 1-ml fraction of infected cell lysates (;3 3
06 cells), 100 ml was removed and set aside as the total
ell extracts (TCE). The remaining 900 ml were centri-
fuged at 700 g for 10 min to pellet nuclei. The pellet was
resuspended in 900 ml of PBS and frozen until needed.
he supernatant was centrifuged at 20,000 g for 30 min
o pellet cytosolic membranous components and whole
irions. The pellet (P20) was resuspended in 900 ml of
PBS and then frozen until needed. The supernatant con-
taining the soluble components of the cytoplasm (S20)
was transferred to another microfuge tube and then
frozen as well.
SDS–PAGE, affinity blots, and fluorography of VV
proteins
For resolution of VV proteins by SDS–PAGE, all sam-
ples were resuspended in 13 reducing SDS–PAGE sam-
ple buffer. To minimize reduction of the thioester-bonded
palmitate, samples were heated to 70°C for 1 min and
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203VV PALMITYLPROTEINSthen rapidly cooled to 4°C prior to loading the gels. All
gels used were 12.5% acrylamide:bisacrylamide (30:0.8).
For affinity blots, SDS–PAGE gels were electroblotted to
nitrocellulose by standard Western blotting techniques
(Towbin et al., 1979) and then probed using Ni1-activated
horseradish peroxidase, which binds histidine-tagged
proteins (see below). The blots were developed using
chemiluminescent reagents and exposure to film. To
detect [3H]PA- or [3H]MA-labeled proteins in gels, the
els were first dehydrated by immersion in DMSO for 30
in. The gels were then impregnated with diphenylox-
zole (PPO) by immersion in a 22.2% PPO:DMSO solution
or 1 h (Bonner and Laskey, 1974). The PPO was precip-
tated in the gel by immersion in water for 30 min. The
els were then dried and exposed to film.
dentification of candidate palmitylproteins
The identification of candidate VV-encoded palmitylpro-
eins was made utilizing a number of criteria. We have
bserved (see Results) that VV palmitylproteins are primar-
ly “late” proteins, have relative molecular masses of 14-, 17-,
3–28 (a single protein), 37-, 42-, 46-, 86-, and 94 kDa, as
etermined by SDS–PAGE, and are specific for EEV. Focus-
ng, then, on VV gene products that matched these criteria,
e then scanned the predicted gene products expressed
y the COP strain of VV for sequences which fit with our
reviously reported palmitylation motif, Hydro*1–12AACA.
Hydro” can be a previously myristylated glycine, a trans-
embrane domain, or a hydrophobic stretch of amino acids
sually at least 10 residues in length. The hydrophobic
lement is usually followed by a 1 to 12-amino-acid spacer
nd then a cysteine (C) residue (or residues) surrounded by
liphatic amino acids (A).
loning and transient expression of candidate
almitylproteins
All of the candidate palmitylprotein genes were
loned into pTM1:6xHis, constructed as follows: The
5R gene of VV was amplified from IHD-J genomic
NA by polymerase chain reaction (PCR) using prim-
rs L5R-59 (59-CCGGAATTCATATGGAGAATGTTCCTA-
TG-39) and L5R-396xHis (59-CCAATGCATTGGTTCTG-
AGTTTCATCAGTGGTGGTGGTGGTGGTGGGATCCTCT-
CGAAGAACATCG-39). The PCR product was treated with
estriction enzyme EcoRI, generating an overhang at the 59
nd of the product and leaving the 39 end blunt, and then
igated into EcoRI/StuI-restricted pTM1, producing the plas-
id pTM1:L5R-6xHis. This placed the 59 end of the L5R
ene downstream of the T7 promoter and encephalo-
yocarditis virus 59-untranslated region/internal ribo-
omal entry site (EMC-leader) on pTM1. The normal
5R stop codon was not included in the PCR primer
nd was, instead, replaced by sequences that, follow-
ng transcription and translation, resulted in the addi-
f
Tion of a glycine and a serine followed by six histidines
t the carboxyl-terminus of the protein.
The remaining candidate palmitylprotein genes
ere cloned into pTM1:L5R-6xHis. To do this, the L5R
oding sequence was excised by restriction with NdeI
nd BamHI, leaving the 6-histidine tag sequence intact
n the plasmid. All other candidate palmitylprotein
enes were PCR amplified from IHD-J genomic DNA,
ith the exception of the A56R gene that was amplified
rom COP and WR genomic DNA as well as IHD-J. The A14L
ene was amplified using primers A14L-59 (59-CCGGAAT-
CATATGGACATGATGCTTATG-39) and A14L-39 (59-GCGG-
ATCCGTTCATGGAAATATCGCTATG-39); the A22R gene
as amplified using primers A22R-59 (59-CCGGAATTCAT
TGTCGTCACCGATG-39) and A22R-39 (59-GCGGGATC-
CATTTTTTTTATGTAATTCCT AG-39); the A33R gene was
mplified using primers A33R-59 (59-CCGGAATTCATATGAT-
ACACCAG-39) and A33R-39 (59-GCGGGATCCGTTCATT-
TTTTAACAC-39); the A34R gene was amplified using
rimers A34R-59 (59-GCATCAGCCCCATATGAAATCGCT-
AATAGACAAACTGTAAG-39) and A34R-39 (59-GCGGGATC-
CTTGTAGAATTTTTTAACAC-39); the A36R gene was am-
lified using primers A36R-59 (59-CCGGAATTCATATGAT-
CTGGTACC-39) and A36R-39 (59-GCGGGATCCCACCAATG
TACG-39); the A56R gene was amplified using primers
56R-59 (59-CCGGAATTCATATGACACGATTACC-39) and
56R-39 (59-GCGGGATCCGACTTTGTTCTCTG-39); the B5R
ene was amplified using primers B5R-59 (59-GCATCAGC-
CCATATGAAAACGATTTCCGTTGTTACGTT-39) and B5R-39
59-GCGGGATCCCGGTAGCAATTTATGG-39); the F13L gene
as amplified using primers F13L-59 (59-GCATCAGC-
CCATATGTGGCCATTTGC-39) and F13L-39 (59-GCGG-
ATCCAATTTTTAACG-39).
All of the PCR products were digested with restriction
nzymes NdeI and BamHI and ligated into NdeI/BamHI-
igested pTM1:L5R-6xHis, producing plasmids pTM1:
14L-6xHis, pTM1:A22R-6xHis, pTM1:A33R-6xHis, pTM1:
34R-6xHis, pTM1:A36R-6xHis, pTM1:A56R(COP)-6xHis,
TM1:A56R(IHD-J)-6xHis, pTM1:A56R(WR)-6xHis, pTM1:
5R-6xHis, and pTM1:F13L-6xHis.
Transient expression of the candidate palmitylproteins
as facilitated by use of the vTF7–3 recombinant VV.
SC40 cells were grown to confluency on 35-mm wells in
ix-well tissue-culture plates (106 cell/well). The cells
were infected with vTF7–3 at a m.o.i. of 10. Following a
1-h virus absorption period, the inoculum was aspirated
and replaced with 500 ml of MEM-E LG/GS containing 10
mg of plasmid DNA complexed with the transfection
reagent DMRIE-C (Gibco-BRL, Grand Island, NY). At 4 hpi
(also 4 h posttransfection) an additional 500 ml of
MEM-E, LG/GS was added. If label was to be added, it
was added with the 500 ml of MEM-E, LG/GS at 4 hpi. At
4 hpi the cells were washed free of the tissue-culture
lates using the culture medium. The cells were pelletedrom the medium by centrifugation at 700 g for 10 min.
he cells were resuspended in 100 ml of PBS containing
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204 GROSENBACH, HANSEN, AND HRUBY5 U of DNase I to reduce the viscosity of the cell lysate,
following lysis by three cycles of freezing and thawing, to
facilitate gel loading. Samples (80 ml) of each of the cell
lysates were set aside for immunoprecipitations. The
remaining 20 ml of cell lysates were made 13 reducing
DS–PAGE sample buffer by addition of 4 ml of 63
reducing SDS–PAGE sample buffer prior to loading gels.
Immunoprecipitation of proteins
Samples (80 ml) of infected cell lysates (;8.0 3 105
cells), labeled during infection with [3H]PA, were diluted
o 1 ml with radioimmunoprecipitation assay (RIPA)
uffer (1% w/v sodium deoxycholate, 1% v/v Triton X-100,
.2% w/v SDS, 150 mM sodium chloride, 50 mM Tris–HCl,
H 7.4). Histidine-tagged proteins were immunoprecipi-
ated by addition of an anti-6-histidine monoclonal anti-
ody (Qiagen, Chatsworth, CA) and protein A-coated
epharose beads. The reactions were performed on a
otary mixer at 4°C for 18 h. The immunoprecipitates
ere washed numerous times with RIPA buffer then
esolved by SDS–PAGE. The gels were fluorographed in
PO:DMSO and exposed to film for detection.
utagenesis of palmitate acceptor residues in VV
almitylproteins
Oligonucleotide (oligo)-directed mutagenesis of VV
almitylprotein genes on pTM1:6xHis plasmids followed
he method of Kunkel et al. (1987). All plasmids resulting
rom the mutagenesis reactions were identical to their
arental plasmids, with the exception of the mutated
odon and novel restriction sites engineered for prelim-
nary screening. The restriction sites did not alter the
oding potential of the genes. All mutations were con-
irmed by DNA sequencing. The codon encoding cys-
eine 99 (C99, numbering from the initiating methionine)
f A22R was mutated to encode serine using oligo A22R-
99S (59-GCCAAAGTGATCAGCGTCTCGCCTGTC-39),
roducing plasmid pTM1:A22R-C99S. The codon encod-
ng C36 of A33R was mutated to encode serine using
ligo A33R-C36S (59-GTGATTGGTCTATCGATTAGA-
TATCTATGG-39), producing plasmid pTM1:A33R-C36S.
he codon encoding C19 of A36R was mutated to en-
ode serine using oligo A36R-C19S (59-GGAACAATAC-
AGTATCTTATATATTATATATTTGTAGG -39), producing
lasmid pTM1:A36R-C19S. The codon encoding C25 of
36R was mutated to encode serine using oligo A36R-
25S (59-GTTAT ATATTATATATCTCGAGGAAAAAGAT-
CG-39), producing plasmid pTM1:A36R-C25S. The
odon encoding C301 of B5R was mutated to encode
erine using oligo B5R-C301S (59-GTTATAGTATT-
GTCTCGAGTTGTGACAAAAATAATGAC -39), producing
lasmid pTM1:B5R-C301S. The codon encoding C303 OF
5R was mutated to encode serine using oligo B5R-
303S (59-GTTATAGTATTAGTTTGCTCGAGTGACAA-
AATAATGAC-39), producing plasmid pTM1:B5R-C303S.n internal region of the F13L open reading frame on
TM1:F13L-6xHis containing codons for C185 and C186
as replaced with the homologous sequence from
DG5.3 (Grosenbach and Hruby, 1998). This plasmid
ontains a copy of F13L but harbors mutations, leading to
he replacement of C185/C186 with serines without al-
ering the otherwise wild-type sequence. This produced
lasmid pTM1:F13L-C185/6S. No mutations were made
o the A56R plasmid. Instead, clones of A56R from COP,
HD-J, and WR DNA were made. The COP and WR se-
uences of the A56R gene are known (Goebel et al.,
990; Smith et al., 1991). The IHD-J A56R DNA was
equenced for comparison to WR and COP. All plasmids
ere sequenced through the cloned genes to ensure
ccuracy of the sequence.
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